sglt2 inhibitors and glp 1 receptor agonists Diabetic Agents, From Metformin to GLP1 Agonists: JACC Focus Seminar Role of GLP-1 Agonists &
Description
This suggests a steady population progressing through the drugs step-up regimen, rather than just trial usage
Garg SK, et al
Andrology, 13 (1), 5567
The GIP component is hypothesized to provide an additional mechanism to buffer against the hyperglycemic effects of glucagon [940], thus permitting triple agonists of higher potency at the glucagon receptor that in theory could drive more body weight loss
[DOI] [PubMed] [Google Scholar] 114.Mathiesen D.S., Bagger J.I., Bergmann N.C., Lund A., Christensen M.B., Vilsbll T., Knop F.K
